An Efficacy and Safety Comparison Study of Two Marketed Drugs in Patients With Relapsing-remitting MS

Completed · Phase 4

Conditions studied: Multiple Sclerosis, Relapsing-Remitting

In brief

The purpose of this study is to determine the difference in preventing a relapse between Betaseron and Avonex. Patients with RRMS currently treated with Avonex will be randomized into 2 equal-size arms; one arm will continue on the standard dose of Avonex; one arm will be converted to Betaseron standard dose.

Key facts

Study ID

NCT00206648

Run by

Bayer

People needed

271

Starts

2003-03-01

Expected to finish

2005-10-01

Last updated by the study team

2014-12-31

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• RRMS patients that are receiving treatment with Avonex 30 µg once weekly

You may not qualify if…

• Primary Progressive or Secondary Progressive MS

Where it is running

• Study site — Berkeley, California, United States
• Study site — Irvine, California, United States
• Study site — Loma Linda, California, United States
• Study site — Los Angeles, California, United States
• Study site — Sacramento, California, United States
• Study site — San Jose, California, United States
• Study site — Walnut Creek, California, United States
• Study site — Walnut Creek, California, United States
• Study site — Wilmington, Delaware, United States
• Study site — Melbourne, Florida, United States
• Study site — Miami, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — Atlanta, Georgia, United States
• Study site — Augusta, Georgia, United States
• Study site — Columbus, Georgia, United States
• Study site — Savannah, Georgia, United States
• Study site — Flossmoor, Illinois, United States
• Study site — Springfield, Illinois, United States
• Study site — Fort Wayne, Indiana, United States
• Study site — Indianapolis, Indiana, United States
• Study site — Des Moines, Iowa, United States
• Study site — Kansas City, Kansas, United States
• Study site — Shreveport, Louisiana, United States
• Study site — Tucson, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.